GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Krebs Biochemicals & Industries Ltd (BOM:524518) » Definitions » Cash Conversion Cycle

Krebs Biochemicals & Industries (BOM:524518) Cash Conversion Cycle : -652.14 (As of Jun. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Krebs Biochemicals & Industries Cash Conversion Cycle?

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

Krebs Biochemicals & Industries's Days Sales Outstanding for the three months ended in Jun. 2024 was 13.48.
Krebs Biochemicals & Industries's Days Inventory for the three months ended in Jun. 2024 was 710.82.
Krebs Biochemicals & Industries's Days Payable for the three months ended in Jun. 2024 was 1376.44.
Therefore, Krebs Biochemicals & Industries's Cash Conversion Cycle (CCC) for the three months ended in Jun. 2024 was -652.14.


Krebs Biochemicals & Industries Cash Conversion Cycle Historical Data

The historical data trend for Krebs Biochemicals & Industries's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Krebs Biochemicals & Industries Cash Conversion Cycle Chart

Krebs Biochemicals & Industries Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cash Conversion Cycle
Get a 7-Day Free Trial Premium Member Only Premium Member Only -87.75 -39.11 -42.45 -62.65 -64.49

Krebs Biochemicals & Industries Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Cash Conversion Cycle Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -828.53 -240.11 -388.76 -15.99 -652.14

Competitive Comparison of Krebs Biochemicals & Industries's Cash Conversion Cycle

For the Drug Manufacturers - Specialty & Generic subindustry, Krebs Biochemicals & Industries's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Krebs Biochemicals & Industries's Cash Conversion Cycle Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Krebs Biochemicals & Industries's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where Krebs Biochemicals & Industries's Cash Conversion Cycle falls into.



Krebs Biochemicals & Industries Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

Krebs Biochemicals & Industries's Cash Conversion Cycle for the fiscal year that ended in Mar. 2024 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=8.79+127.39-200.67
=-64.49

Krebs Biochemicals & Industries's Cash Conversion Cycle for the quarter that ended in Jun. 2024 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=13.48+710.82-1376.44
=-652.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Krebs Biochemicals & Industries  (BOM:524518) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


Krebs Biochemicals & Industries Cash Conversion Cycle Related Terms

Thank you for viewing the detailed overview of Krebs Biochemicals & Industries's Cash Conversion Cycle provided by GuruFocus.com. Please click on the following links to see related term pages.


Krebs Biochemicals & Industries Business Description

Traded in Other Exchanges
Address
Kothapalli Village, Kasimkota Mandal, Anakapalli, Vishakapatnam, AP, IND, 531 031
Krebs Biochemicals & Industries Ltd is a biochemical company in India. It is engaged in the business of manufacture of active pharmaceutical ingredients. It has two manufacturing plants in Andhra Pradesh, India - one in Nellore and one in Vizag both Units are equipped for chemical synthesis, fermentation, and enzymatic technologies providing Krebs with production capacity.

Krebs Biochemicals & Industries Headlines

No Headlines